IRD FY 2021 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$589,000

Gross Profit

$589,000100.0% margin

Operating Income

-$23M-3854.8% margin

Net Income

-$57M-9625.3% margin

EPS (Diluted)

$-3.82

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$26M

Total Liabilities

$4M

Stockholders' Equity

$22M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$589,000	$0	—
Gross Profit	$589,000	$0	—
Operating Income	-$23M	-$20M	-13.7%
Net Income	-$57M	-$25M	-130.3%